Увійти

Готові списки джерел за темами / Relapsers

Зміст

Статті в журналах
Дисертації
Книги
Частини книг
Тези доповідей конференцій
Звіти організацій

Добірка наукової літератури з теми "Relapsers"

Автор: Grafiati

Опубліковано: 3 червня 2025

Оновлено: 31 липня 2025

Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями

Оберіть тип джерела:

Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Relapsers".

Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.

Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.

Статті в журналах з теми "Relapsers"

1

Freedman, MS, S. Broadley, A. Chinea, et al. "A.03 Durable clinical and MRI efficacy of alemtuzumab over 6 years in CARE-MS II patients with RRMS who relapsed between Courses 1 and 2." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 45, s2 (2018): S10. http://dx.doi.org/10.1017/cjn.2018.84.

Повний текст джерела

Анотація:

Background: In RRMS patients with inadequate response to prior therapy, 2 alemtuzumab courses (12 mg/day; baseline: 5 days; 12 months later: 3 days) significantly improved outcomes over 2 years (y) versus SC IFNB-1a (CARE-MS II [NCT00548405]), with durable efficacy over a 4-y extension (NCT00930553). We present 6-y efficacy (2-y core study plus 4-y extension) in patients with relapse (relapsers) between Courses (C) 1 and 2. Methods: Annualized relapse rate (ARR); 6-month confirmed disability worsening (CDW); MRI disease activity (Gd-enhancing lesions; new/enlarging T2 hyperintense lesions); br

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Minj, Simpal Shalini, Surbhi Rathi, Santosh Kondekar, and Jane J. E. David. "Study of risk factors for relapse in frequently versus infrequently relapsing nephrotic syndrome in 1-18 year age group: a combined prospective retrospective cohort analytical observational study." International Journal of Contemporary Pediatrics 6, no. 2 (2019): 803. http://dx.doi.org/10.18203/2349-3291.ijcp20190733.

Повний текст джерела

Анотація:

Background: Early prediction and prevention of risk factors is the key to successful management of childhood nephrotic syndrome. This study was carried out to find the risk factors of relapse which will help in early prediction and reduce the risk of relapse in childhood nephrotic syndrome.Methods: It was a combined prospective-retrospective cohort analytical observational study of duration 18 months with sample size of 80 patients of age group 1-18 years who fulfilled the inclusion and exclusion criteria. The variables taken into account for the present study were demographic and disease rela

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Sangeetha, A., S. Sudhakar, I. Ilavarasan, and P. P. Kannan. "A follow – Up study on coping strategies and its association with relapse among alcohol dependent patients." Panacea Journal of Medical Sciences 14, no. 2 (2024): 446–52. http://dx.doi.org/10.18231/j.pjms.2024.080.

Повний текст джерела

Анотація:

Alcohol consumption is a major problem in India. Alcohol dependence develops due to various factors, like individuals’ characteristics and social factors. The study was done to analyze coping strategies in relation to alcohol dependence and relapse.A follow-up study was conducted among 103 patients who attended the Psychiatry department for de – addiction treatment in a tertiary care centre in Chengalpattu, Tamil Nadu. A validated semi-structured questionnaire was used to collect details of Socio-demographic characteristics. The Severity of Alcohol Dependence Questionnaire and the Brief-COPE q

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Shilliday, I. R., K. Simpson, R. Jackson, A. L. McLay, and M. Boulton-Jones. "Minimal Change Nephropathy in the West of Scotland: A Review of Sixty-Four Patients." Scottish Medical Journal 38, no. 3 (1993): 70–72. http://dx.doi.org/10.1177/003693309303800303.

Повний текст джерела

Анотація:

Sixty-four patients with a histological diagnosis of minimal change nephropathy have been followed for a median of 110 months. Patients transferred from paediatric units (11%) had a worse prognosis in that all became frequent relapsers. Patients who relapsed within three months or who went on to become frequent relapsers had a higher 24 hour urine protein excretion at presentation than patients who did not relapse. After fifteen months of remission relapse was rare; 97% of those who relapsed did so within 36 months. Patients who have been off steroids and proteinuria free for 36 months might t

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Nassif, Elise F., Chia-Chin Wu, Kadir Akdemir, et al. "Abstract PR002: Antigen presentation and processing pathway is associated with early relapse after neoadjuvant immune checkpoint blockade (ICB) in dedifferentiated liposarcomas (DDLPS)." Clinical Cancer Research 28, no. 18_Supplement (2022): PR002. http://dx.doi.org/10.1158/1557-3265.sarcomas22-pr002.

Повний текст джерела

Анотація:

Abstract Background: We evaluated the activity of neoadjuvant ICB in localized resectable DDLPS (n=17) and undifferentiated pleomorphic sarcomas (UPS; n=10). DDLPS and UPS patients were randomized to neoadjuvant nivolumab or ipilimumab+nivolumab, with UPS patients receiving concurrent radiotherapy. We assessed genomic markers of early relapse (progression before surgery or relapse within 52 weeks following surgery) using longitudinally acquired tumor samples. Methods: RNA sequencing (RNAseq) and whole genome sequencing (WGS) were performed on longitudinally acquired samples (baseline biopsies

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Van Wijmeersch, Bart, Barry A. Singer, Aaron Boster, et al. "Efficacy of alemtuzumab over 6 years in relapsing–remitting multiple sclerosis patients who relapsed between courses 1 and 2: Post hoc analysis of the CARE-MS studies." Multiple Sclerosis Journal 26, no. 13 (2019): 1719–28. http://dx.doi.org/10.1177/1352458519881759.

Повний текст джерела

Анотація:

Background: Alemtuzumab is administered as two annual courses for relapsing–remitting multiple sclerosis (MS). Patients may relapse before completing the two-course regimen. Objective: The objective was to evaluate 6-year outcomes in patients who relapsed between alemtuzumab Courses 1 and 2 (early relapsers). Methods: Post hoc analysis of patients from the Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis (CARE-MS) studies who enrolled in the extension. Results: Early relapsers (CARE-MS I: 15%; CARE-MS II: 24%) had more relapses in 1–2 years pre-alemtuzumab and higher mean ba

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Massimino, Maura, Francesca Romana Buttarelli, Hendrik Witt, et al. "EPEN-03. LONG-TERM FOLLOW-UP OF AIEOP 2ND SERIES OF CHILDREN AND ADOLESCENT WITH PRIMARY INTRACRANIAL (ST:SUPRATENTORIAL; PF: POSTERIOR FOSSA) EPENDYMOMA AND METHYLATION GROUPS RE-ANALYSES." Neuro-Oncology 22, Supplement_3 (2020): iii308. http://dx.doi.org/10.1093/neuonc/noaa222.144.

Повний текст джерела

Анотація:

Abstract BACKGROUND This 2002–2014 Italian prospective study stratified 160 patients by surgical resection (complete=NED/incomplete=ED) and centrally-reviewed grade. Grade2/NED patients received focal radiotherapy (RT) up to 59.4Gy, Grade3/NED received 4 courses of VEC(vincristine,etoposide,cyclophosphamide) after RT.ED patients received 1–4 VEC courses, second-look surgery, 59.4 Gy+8Gy boost on measurable residue. METHODS We re-analyzed data at 115 months follow-up including methylation profile on available samples. RESULTS Global PFS/OS at 5/10 years were 66/59% and 80/74%, respectively. Of

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Berti, A., S. Hillion, A. Hummel, et al. "THU0040 PROTEINASE 3-REACTIVE B CELL RECONSTITUTION AFTER TREATMENT WITH RITUXIMAB FOR ANCA-ASSOCIATED VASCULITIS." Annals of the Rheumatic Diseases 79, Suppl 1 (2020): 233.1–233. http://dx.doi.org/10.1136/annrheumdis-2020-eular.5169.

Повний текст джерела

Анотація:

Background:Proteinase 3 (PR3)-reactive B cells are present in PR3-ANCA-associated vasculitis (AAV) at levels higher than healthy controls.Objectives:To evaluate the dynamics of the PR3-reactive B cell repopulation in patients with PR3-AAV after treatment with rituximab, and to analyze possible associations between these immunological changes and long-lasting remissions.Methods:We analyzed all available frozen peripheral blood mononuclear cells (n=148) from 23 randomly-selected PR3-AAV patients who participated in the RAVE trial and achieved complete remission (BVAS=0, prednisone=0) after treat

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Soman, S., and A. Vr. "The prevalence of psychiatric comorbidities and relapses in males treated for alcohol dependence syndrome – Prospective study from tertiary de-addiction care unit in Kerala, India." European Psychiatry 41, S1 (2017): s879. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1774.

Повний текст джерела

Анотація:

Kerala has high percapita consumption of alcohol among the other Indian states.ObjectivesPrevalence of psychiatric comorbidities in alcohol dependence syndrome and association of severity of alcohol dependence, personality dimensions, motivation and short delay relapses.MethodsA prospective study in 91 male alcoholic patients for 2 months.ResultsTwo groups not relapsed (NR = 48) and Relapsed (R = 43) were comparable in age, SADQ severity score, average units of alcohol consumption and years of alcohol use. Average consumption was 17 units/day (500 mL spirits), age of onset before 25 years 87%,

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Murphy, E., J. Douglas, Q. Qi, and L. Wood. "Relapse patterns and outcomes in a population-based study of Nova Scotia patients with germ cell tumors (GCT)." Journal of Clinical Oncology 25, no. 18_suppl (2007): 15564. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.15564.

Повний текст джерела

Анотація:

15564 Objectives: To examine the frequency and pattern of relapse in a population-based cohort of Nova Scotia patients with germ cell tumors (GCT). Presentation and outcome of these patients will be described with an emphasis on late relapsers. Methods: A retrospective chart review of all patients diagnosed with GCT in Nova Scotia between 1984 and 2004 was completed. Data regarding initial diagnosis and treatment as well as data at time of relapse was collected. Relapse was defined as any recurrence of tumor after initial definitive therapy. Late relapse (LR) was defined as a relapse >2 yea

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Дисертації з теми "Relapsers"

1

Elal-Lawrence, G. "Characteristics discriminating successfully treated abstainers and controlled drinkers from relapsers." Thesis, University of Liverpool, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.382051.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Agboola, Shade. "Smoking relapse prevention : abstinence, relapse, current practice and effective interventions." Thesis, University of Nottingham, 2017. http://eprints.nottingham.ac.uk/43623/.

Повний текст джерела

Анотація:

Smoking remains a major cause of morbidity and mortality. In 2013/2014, 454,700 hospital admissions in the UK amongst persons 35 years and over were estimated to be attributable to smoking. This accounts for 4 per cent of all hospital admissions in this age group. In 2013, 17% (78,200) of all deaths in adults aged 35 and over were estimated to be caused by smoking[1]. Reducing smoking therefore, remains a major priority for governments and health systems like the UK National Health Service (NHS). Following the publication of the Government’s White Paper, Smoking Kills[2] in 1998, a comprehensi

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Malkus, Amy J. "Relapse Prevention Manual." Digital Commons @ East Tennessee State University, 2002. https://dc.etsu.edu/etsu-works/4700.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Caravati, Paula Ciavarella. "Obesity Relapse in Women." Diss., Virginia Tech, 2001. http://hdl.handle.net/10919/26817.

Повний текст джерела

Анотація:

Obesity and relapse after dieting pose a significant threat to an increasing number of adults in this country. Resistance to treatment and high relapse rates make this problem frustrating for patients and practitioners. There is limited research on relapse causation; research on social and life circumstance factors is uncommon. Given the limitations of existing research, the purpose of this study was to investigate the natural course of obesity relapse. A purposive sample of eight obese women, ages 31-57, was selected. All of the women relapsed at least one or more times throughout their li

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Klein, Jeffery Lane. "Attributional style and alcoholic relapse /." Diss., Connect to a 24 p. preview or request complete full text in PDF format. Access restricted to UC campuses, 1997. http://wwwlib.umi.com/cr/ucsd/fullcit?p9804031.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Bowersox, Nicholas W. "Treatment Attrition and Relapse Readmission in Psychiatric Inpatients: Predictors of Treatment Engagement and Psychiatric Relapse." [Milwaukee, Wis.] : e-Publications@Marquette, 2009. http://epublications.marquette.edu/dissertations_mu/18.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Paseman, Wallace W. "Relapse Prevention Using Mobile Electronic Media." Thesis, State University of New York Empire State College, 2017. http://pqdtopen.proquest.com/#viewpdf?dispub=10278346.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Morrison, Fraser. "Predictors of relapse in alcohol dependence." Thesis, University of Edinburgh, 2008. http://hdl.handle.net/1842/24999.

Повний текст джерела

Анотація:

Relapse rates following treatment for alcohol dependence are high, and efforts to prevent relapse are an integral part of treatment. Outcome studies have reported relapse rates of 65% within one year of treatment, with the majority relapsing within less than three months. Many factors have been studied as potential predictors of relapse in alcohol dependence, such as psychiatric disorder. Fifty four residents in an inpatient alcohol detoxification unit were tested on measures of memory and executive functioning, mood, self efficacy, quality of life, and liver function at the end of a seven to

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Ramo, Danielle Elizabeth. "Developmental models of substance abuse relapse." Diss., Connect to a 24 p. preview or request complete full text in PDF format. Access restricted to UC campuses, 2008. http://wwwlib.umi.com/cr/ucsd/fullcit?p3297587.

Повний текст джерела

Анотація:

Thesis (Ph. D.)--University of California, San Diego and San Diego State University, 2008.<br>Title from first page of PDF file (viewed April 28, 2008). Available via ProQuest Digital Dissertations. Vita. Includes bibliographical references.

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Byrne, Susan Mary. "Weight maintenance and relapse in obesity." Thesis, University of Oxford, 2001. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.393355.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Книги з теми "Relapsers"

1

Abuse, National Institute on Drug. Introducing relapse prevention. National Institutes of Health ; National Institute on Drug Abuse, 1993.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Turner, Nikki. Relapse: A novel. One World Trade Paperbacks-Ballantine Books, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

National Institute on Drug Abuse. Introducing relapse prevention. National Institutes of Health ; National Institute on Drug Abuse, 1993.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

National Institute on Drug Abuse. Introducing relapse prevention. National Institutes of Health ; National Institute on Drug Abuse, 1993.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Richards, C. Steven, and Michael G. Perri, eds. Relapse prevention for depression. American Psychological Association, 2010. http://dx.doi.org/10.1037/12082-000.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Jon, Carlson, American Psychological Association, and Governors State University. Division of Digital Learning and Media Design, eds. Relapse prevention over time. American Psychological Association, 2007.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

1948-, Gossop Michael, ed. Relapse and addictive behaviour. Tavistock/Routledge, 1989.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Richards, C. Steven. Relapse prevention for depression. American Psychological Association, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Steven, Richards C., Perri Michael G, and American Psychological Association, eds. Relapse prevention for depression. American Psychological Association, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Association, American Psychological, ed. Relapse prevention for depression. American Psychological Association, 2010.

Знайти повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Більше джерел

Частини книг з теми "Relapsers"

1

Petta, Salvatore, and Antonio Craxì. "Genotype 1 Relapsers and Non-Responders." In Advanced Therapy for Hepatitis C. Wiley-Blackwell, 2011. http://dx.doi.org/10.1002/9781444346343.ch11.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Serroukh, Yasmina, and Silvia Montoto. "Indolent Lymphoma." In The EBMT Handbook. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-44080-9_84.

Повний текст джерела

Анотація:

AbstractIndolent lymphomas (iNHL) form an heterogenous group accounings for 1/3 of all malignant lymphomas with Follicular lymphoma (FL) being the most common subtype. iNHL are characterized by repeated relapses. Among available treatment lines, autologous (auto) and allogeneic (allo) HCT are the only curative options for relapsed disease. Nevertheless, the roles of both forms of HCT are evolving and are currently being challenged as T-cell engaging therapies emerge. The indications for auto-HCT and allo-HCT in 2023 are reviewed in this chapter.

Стилі APA, Harvard, Vancouver, ISO та ін.

3

NíChonghaile, Mairéad. "Graft Versus Tumour Effect." In The European Blood and Marrow Transplantation Textbook for Nurses. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-23394-4_13.

Повний текст джерела

Анотація:

AbstractThe treatment of relapsed disease remains challenging, and it is well accepted that concept of allogeneic HSCT relies upon both the conditioning or preparative regimen used for the recipient and the graft versus malignancy (GvM) or leukaemia (GvL) effect provided by the donor T cells and NK cells. Strategies which involve harnessing this effect are crucial to success and need to be exploited and refined to improve outcome. Further research is required to identify new strategies and therapies to improve the outlook for patients who relapse post-HSCT.The nursing challenges following rela

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Peters, Christina, Franco Locatelli, and Peter Bader. "Acute Lymphoblastic Leukaemia in Children and Adolescents." In The EBMT Handbook. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-44080-9_73.

Повний текст джерела

Анотація:

AbstractAcute lymphoblastic leukaemia (ALL) is the most common cancer in children; approximately 60% of ALL cases occur in children and adolescents under the age of 20. Allogeneic haematopoietic cell transplantation (HCT) has become the most commonly used cellular immunotherapy and the standard of care for children with ALL who are either at high risk of relapse or have previously relapsed. HCT is a successful therapeutic option and a significant proportion of patients achieve long-term survival. The most common cause of treatment failure is relapse after allogeneic HCT. The risk of relapse af

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Lustyk, M. Kathleen B., and Gabriana Navarrete. "Relapse, Relapse Prevention." In Encyclopedia of Behavioral Medicine. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-39903-0_276.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Molina, Kristine M., Kristine M. Molina, Heather Honoré Goltz, et al. "Relapse, Relapse Prevention." In Encyclopedia of Behavioral Medicine. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4419-1005-9_276.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Lustyk, M. Kathleen B., and Gabriana Navarrete. "Relapse, Relapse Prevention." In Encyclopedia of Behavioral Medicine. Springer New York, 2020. http://dx.doi.org/10.1007/978-1-4614-6439-6_276-2.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Stelljes, Matthias, David I. Marks, and Sebastian Giebel. "Acute Lymphoblastic Leukemia in Adults." In The EBMT Handbook. Springer International Publishing, 2024. http://dx.doi.org/10.1007/978-3-031-44080-9_72.

Повний текст джерела

Анотація:

AbstractThe prognosis of patients with acute lymphoblastic leukemia is constantly improving. Beside optimization strategies of conventional chemotherapies and close monitoring of treatment response (e.g. by PCR-based measurement of measurable disease, which helps to early identify patients at risk for relapse), the integration of antibody (e.g. anti-CD20)/antibody-based drugs (blinatumomab and inotuzumab-ozogamicin) to frontline and/or salvage therapy protocols led to significant improvements. However, allogeneic HCT still plays a fundamental role in the treatment of high-risk patients in 1st

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Melemis, Steven M. "Relapse and Relapse Prevention." In Alcohol Use: Assessment, Withdrawal Management, Treatment and Therapy. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-18381-2_22.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Floresco, Stan, Robert Kessler, Ronald L. Cowan, et al. "Relapse." In Encyclopedia of Psychopharmacology. Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_544.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

Тези доповідей конференцій з теми "Relapsers"

1

Górzyński, Kamil, Anna Plęs, Ivan Ryzhankow, and Bartłomiej Zych. "Bumblebee Your Way to Recovery: Transforming The Approach to Detection of Mental Health Relapses." In 2024 IEEE International Conference on Acoustics, Speech, and Signal Processing Workshops (ICASSPW). IEEE, 2024. http://dx.doi.org/10.1109/icasspw62465.2024.10626747.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Tripathi, Mukesh Kumar, Meka Ananya, V. N. L. N. Murthy, Tumma Shashank, Jale Subash Reddy, and Kaushal Attaluri. "Enhanced Breast Cancer Relapse Prediction using Ensemble Learning Techniques." In 2024 4th International Conference on Sustainable Expert Systems (ICSES). IEEE, 2024. https://doi.org/10.1109/icses63445.2024.10763119.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Khatri, Radhika, Faryal Khan, and Shah Jamal Alam. "Risk Identification and Relapse Prediction in Lung Adenocarcinoma (LUAD)." In 2024 International Conference on Artificial Intelligence, Metaverse and Cybersecurity (ICAMAC). IEEE, 2024. https://doi.org/10.1109/icamac62387.2024.10828988.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Kaliosis, Panagiotis, Sofia Eleftheriou, Christos Nikou, and Theodoros Giannakopoulos. "A Self-Supervised Learning Approach for Detecting Non-Psychotic Relapses Using Wearable-Based Digital Phenotyping." In 2024 IEEE International Conference on Acoustics, Speech, and Signal Processing Workshops (ICASSPW). IEEE, 2024. http://dx.doi.org/10.1109/icasspw62465.2024.10627012.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Cabral, Samira Marcondes, Marcelo Antonini, Raissa Naiara Barros Vasconcelos, Mariana Soares Cardoso, and Matheus de Paula Solino. "IMPACT OF LOCAL RECURRENCE ON PATIENTS WITH BREAST CANCER DIAGNOSIS SUBMITTED TO CONSERVATIVE SURGERY AT HOSPITAL PÚBLICO DO SERVIDOR ESTADUAL." In Scientifc papers of XXIII Brazilian Breast Congress - 2021. Mastology, 2021. http://dx.doi.org/10.29289/259453942021v31s1060.

Повний текст джерела

Анотація:

Introduction: Breast cancer is a major cause of mortality in Brazil and worldwide. It is a heterogeneous disease with specific molecular subtypes, which are associated with different prognosis and responses to treatment. Objectives: The present study aimed at assessing the incidence of local recurrence in patients undergoing conservative surgery and its impact on overall survival. As a secondary outcome, there are the prognostic factors of local recurrence in addition to the relationship with systemic metastasis. Methods: It is a retrospective cohort including 500 patients submitted to conserv

Стилі APA, Harvard, Vancouver, ISO та ін.

6

"O-008 - CLOZAPINE TREATMENT AND ACUTE RELAPSE'S PREVENTION IN DUAL DIAGNOSIS PATIENTS." In 24 CONGRESO DE LA SOCIEDAD ESPAÑOLA DE PATOLOGÍA DUAL. SEPD, 2022. http://dx.doi.org/10.17579/abstractbooksepd2022.o008.

Повний текст джерела

Анотація:

Objectives: to analyze prescription pattern of clozapine in dual diagnosis (DD) inpatients' and to find out if there was any association with acute relapses either from psychiatric symptoms or from substance use disorder. Material and Methods: a retrospective study was conducted with all patients admitted at Lisbon's Psychiatric Hospital Center for psychiatric inpatient treatment during a 4 months' period. Patients with a dual diagnosis at discharge were selected and their clinical files were screened to assess sociodemographic and clinical information. Results and conclusions: from a total of

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Eldor, A., and M. Rose. "RELAPSING THROMBOTIC THROMBOCYTOPENIA PURPURA (TTP): A CLINICAL STUDY OF 38 PATIENTS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644590.

Повний текст джерела

Анотація:

A dramatic change in the prognosis of TTP has taken place since the introduction of plasma therapy in 1977. However, plasma therapy does not always result in a complete cure since TTP manifestation may reappear. We describe 38 patients who were treated for TTP in 15 hospitals in Israel and New York City since 1977. 37 patients received plasma (transfusions and exchanges) and 30 survived. 12 patients (37%) developed relapsing TTP. Infections, pregnancy and surgery frequently preceded the initial episodes and the relapses. To evaluate the clinical course of relapsing TTP, a scoring system was de

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Cruz, Marta Arnáez De La, Victor Lago, Sandra Florez Herrero, et al. "#618 Multicenter analysis of the relapse pattern and treatment in relapsed endometrial cancer." In ESGO 2023 Congress. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/ijgc-2023-esgo.354.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Viana, Beatriz, Ricardo Machado, William B. Stiles, João Salgado, Patrícia Pinheiro, and Isabel Basto. "THE ASSIMILATION PROCESS OF PROBLEMATIC EXPERIENCES AND LONG-TERM OUTCOMES IN PSYCHOTHERAPY FOR DEPRESSION: COMPARING A RELAPSED AND A NON-RELAPSED CASE." In International Psychological Applications Conference and Trends. inScience Press, 2021. http://dx.doi.org/10.36315/2021inpact007.

Повний текст джерела

Анотація:

"Over the years, research has demonstrated that psychotherapy is an effective treatment in different psychopathological conditions. However, which are the mechanisms or processes involved in therapeutic change that could explain its efficacy are not yet clear. The Assimilation of Problematic Experiences Model describes change in therapy as a process that occurs through the gradual assimilation of problematic experiences in the self – higher levels of assimilation seem to be associated with a better outcome at the end of therapy. However, little is known about the contribution of this process t

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Mukherjee, Kalyan K., Debasish Banerjee, Anjan Das, et al. "Significance of Detecting Minimal Residual Disease by Flow Cytometry and its Impact on Overall Survival and Prognosis of Pediatric B-Cell ALL Patient Experience from a Tertiary Care Centre in Eastern India." In Annual Conference of Indian Society of Medical and Paediatric Oncology (ISMPO). Thieme Medical and Scientific Publishers Pvt. Ltd., 2021. http://dx.doi.org/10.1055/s-0041-1735366.

Повний текст джерела

Анотація:

Abstract Introduction The improved prognosis of pediatric B-cell acute lymphoblastic leukemia (pBALL) is considered as a good progress of medical science in the field of oncology and hematology. Minimal residual disease (MRD) refers to presence of disease in molecular level is a newer practice with respect to the detection of complete remission by conventional pathologic analysis. Prognostic value of MRD in pediatric ALL (p-ALL) is well known. Objectives This study was aimed to describe clinical outcomes and prognosis, that is, overall survival and relapse in the patients with pBALL with respe

Стилі APA, Harvard, Vancouver, ISO та ін.

Звіти організацій з теми "Relapsers"

1

Lewis, Natalie, Mallory Johnson, Tyler Halle-Todd, Natalie Ragland, and Sharon Little. LAI Antipsychotics vs. Oral Antipsychotics: Treatment adherence, Relapses, and Readmissions. University of Tennessee Health Science Center, 2024. http://dx.doi.org/10.21007/con.dnp.2024.0079.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

2

Woody, George E., Sabrina Poole, Elmer Yu, and Kevin G. Lynch. Helping People with Opioid Use Disorders Avoid Relapses after Leaving Jail. Patient-Centered Outcomes Research Institute (PCORI), 2021. http://dx.doi.org/10.25302/01.2021.cer-1409-21688.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

3

Hashim, Zia, Alok Nath, Mansi Gupta, Ajmal Khan, Ajit Kumar Jha, and Anup Kumar. Sarcoidosis Relapse: Systematic Review and Metanalysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2023. http://dx.doi.org/10.37766/inplasy2023.8.0056.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

4

Lin, Zhijuan, Xing Chen, Long Liu, Zhifeng Li, and Bing Xu. Chemo-Free Treatments in Relapsed and/or Refractory Follicular Lymphoma: A Network Meta-Analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.11.0111.

Повний текст джерела

Анотація:

Review question / Objective: FL is the most common indolent B cell lymphoma worldwide and patients with FL always have long term survival. However, advanced FL remains incurable and there is no universal agreement on optimal regimen to manage relapsed FL. Condition being studied: The efficacy of chemo-free regimens, including CD20 antibodies and targeted agents, in relapsed and/or refractory Follicular lymphoma. Information sources: We used the MEDLINE, Embase, and Cochrane Library databases to search the RCTs met our selection criteria. We also searched clinicalTrials.gov and the internationa

Стилі APA, Harvard, Vancouver, ISO та ін.

5

Karadeniz, Meltem. The hunt for a signature of MS relapse. Edited by Suzannah Lyons. Monash University, 2024. http://dx.doi.org/10.54377/59b7-2eef.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

6

Sriuranpong, Virote. The role of SHP-1 promoter 2 hypermethylation detection of lymph node micrometastasis in resectable nonmetastasis NSCLC as a prognostic marker of disease. Chulalongkorn University, 2010. https://doi.org/10.58837/chula.res.2010.16.

Повний текст джерела

Анотація:

Introduction; Despite adequate surgical management of stage I non-small cell lung cancer, many patients still have relapsed of disease which leads to mortality. Micrometastasis of tumor is the postulate mechanism which might not be detected by standard H&E method. The author conducted the study of epithelial methylation marker, SHP-1 Promoter 2 (SHP1P2) methylation as a potential molecular marker to detect high risk relapsed of disease in stage I resectable non-small cell lung cancer (NSCLC). Method; To explore the potential role of SHP1P2 methylation to detect micrometastasis, Lymph node

Стилі APA, Harvard, Vancouver, ISO та ін.

7

Timm, Eliane, Julia Vieregg, and Ursula Wolf. Movement based mindfulness therapies in patients with multiple sclerosis – a systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.2.0102.

Повний текст джерела

Анотація:

Review question / Objective: The aim is to review the clinical benefits of mindful moving techniques for persons with multiple sclerosis. Condition being studied: Multiple sclerosis. Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (Gholamzad et al., 2019; Oh, Vidal-Jordana, & Montalban, 2018). It has shown to be increasing since 2013, and as of 2020 the estimated number of people with MS is 2.8 million worldwide (Walton et al., 2020). Due accumulation of relapses or gradual progression, disability from MS is worsening over time (Cameron & Ni

Стилі APA, Harvard, Vancouver, ISO та ін.

8

Conway, Terry L. Improving Navy Women's Health: Preventing Smoking Relapse After Recruit Training. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada370229.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

9

Buckley, Jonathan D. Predicting Time-to-Relapse in Breast Cancer Using Neural Networks. Defense Technical Information Center, 1995. http://dx.doi.org/10.21236/ada300396.

Повний текст джерела

Стилі APA, Harvard, Vancouver, ISO та ін.

10

Kennedy, Sara M., and Rania Ali. Baclofen for Alcohol Use Disorder: A Cochrane Review Summary With Commentary. RTI Press, 2025. https://doi.org/10.3768/rtipress.2025.rb.0040.2502.

Повний текст джерела

Анотація:

This brief summarizes the Cochrane Review, “Baclofen for Alcohol Use Disorder,” by R. Agabio, R. Saulle, S. Rösner, and S. Minozzi (https://doi.org/10.1002/14651858.CD012557.pub3). The Cochrane Review examines evidence for benefits and harms of baclofen on achieving and maintaining abstinence or reducing alcohol consumption in people with alcohol use disorder (AUD) compared to placebo, no treatment, or any other pharmacological relapse prevention treatment. Review authors conclude that baclofen likely reduces the risk of relapse to any drinking and increases the percentage of abstinent days, m

Стилі APA, Harvard, Vancouver, ISO та ін.

Ми пропонуємо знижки на всі преміум-плани для авторів, чиї праці увійшли до тематичних добірок літератури. Зв'яжіться з нами, щоб отримати унікальний промокод!